Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
Conserved Binding Sites01:49

Conserved Binding Sites

Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High performance of point-of-care rapid tests for advanced HIV disease diagnosis by lay providers in Malawi: Results from a prospective diagnostic accuracy study supporting decentralized advanced HIV disease screening.

PloS one·2026
Same author

Developing a surveillance system for HIV pre-exposure prophylaxis (PrEP) use in pregnancy in Malawi.

BMC pregnancy and childbirth·2026
Same author

HIV low-level viraemia: considerations for prevention and treatment in an era of highly effective and durable antiretroviral therapy regimens.

Journal of the International AIDS Society·2026
Same author

"I just thought I was lucky to be protected from HIV:" Qualitative evaluation of barriers and facilitators of pre-exposure prophylaxis use for adolescent girls and young women at higher risk of HIV acquisition in Lilongwe, Malawi.

PloS one·2025
Same author

HIV Drug Resistance to Dolutegravir Among Adults Investigated for Antiretroviral Treatment Failure in Malawi: A 2023 National Cross-Sectional Survey.

Journal of acquired immune deficiency syndromes (1999)·2025
Same author

The changing landscape of medicinal chemistry optimization.

Nature reviews. Drug discovery·2025
Same journal

Unified heterogeneity-aware benchmark of drug synergy prediction: a cross-study analysis of traditional machine learning and graph deep learning models.

Journal of cheminformatics·2026
Same journal

Count your bits: fingerprint benchmarking to assess broad chemical space representation.

Journal of cheminformatics·2026
Same journal

Sampling out-of-distribution chemical spaces via Bayesian flow.

Journal of cheminformatics·2026
Same journal

Hold on tight: the kinetic profiling of opioid receptor ligands using the CORAL-MD.

Journal of cheminformatics·2026
Same journal

Transformer-accelerated discovery of inhibitors targeting the RpsA<sub>Δ438</sub> deletion in PZA-resistant tuberculosis.

Journal of cheminformatics·2026
Same journal

DICL: a manually curated database of ion channels and ligands as a useful platform for drug discovery targeting ion channels.

Journal of cheminformatics·2026
See all related articles

Related Experiment Video

Updated: Jun 16, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Optimal assignment methods for ligand-based virtual screening.

Andreas Jahn1, Georg Hinselmann, Nikolas Fechner

  • 1University of Tübingen, Center for Bioinformatics Tübingen (ZBIT), Sand 1, 72076 Tübingen, Germany.

Journal of Cheminformatics
|February 13, 2010
PubMed
Summary
This summary is machine-generated.

Optimal assignment methods on molecular graphs improve scaffold-hopping in drug discovery virtual screening. These methods enhance early recognition of active structures and offer interpretable results with low computation times.

More Related Videos

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

Related Experiment Videos

Last Updated: Jun 16, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

Area of Science:

  • Computational chemistry
  • Drug discovery
  • Cheminformatics

Background:

  • Ligand-based virtual screening is crucial for early drug discovery, aiming to identify novel chemical scaffolds.
  • Existing similarity methods struggle with scaffold-hopping, limiting the discovery of diverse active molecules.
  • The optimal assignment approach on molecular graphs, successful in QSAR, remains untested for virtual screening.

Purpose of the Study:

  • To evaluate existing and novel optimal assignment methods for ligand-based virtual screening.
  • To assess the scaffold-hopping capabilities of these methods using chemotype clustering.
  • To compare their early recognition performance against literature benchmarks.

Main Methods:

  • Evaluation of two published and two new optimal assignment methods.
  • Utilizing chemotype clustering information for performance metrics.
  • Comparative analysis against established literature results.

Main Results:

  • Improved early recognition performance in virtual screening compared to literature.
  • Comparable overall dataset results with enhanced scaffold-hopping ability.
  • A novel two-step assignment method demonstrated superior scaffold-hopping and early recognition.

Conclusions:

  • Optimal assignment methods effectively combine chemotype discovery with active structure enrichment.
  • The approach allows for interpretable mappings and parameter modification for target-specific tuning.
  • Low computational times make these methods suitable for large-scale virtual screening.